|
Over the past 25 years, diagnoses of Leukemia and Lymphoma have increased by 88% and 87% respectively. Learn more about the current options available to treat these types of cancers, and hear a first-hand account of a patient’s incredible story of survival following an experimental form of treatment. Guests will include Lee M. Nadler, MD, Senior Vice President of Experimental Medicine, Dana-Farber Cancer Institute (DFCI), and Director, DFCI Center for Clinical and Translational Research; Charles R. Scheper, non-Hogdkin’s Lymphoma survivor, COO, Great American Financial Resources, Inc., and C
|
